FRI-355-Elafibranor, a drug candidate for first line NASH monotherapy and a universal backbone for drug combination treatment von Legry, Vanessa, Descamps, Emeline, Noel, Benoit, Foucart, Corinne, Degallaix, Nathalie, Belanger, Carole, Hum, Dean W., Mégnien, Dr. Sophie, Staels, Prof. Bart, Loomba, Prof. Rohit, Harrison, Prof. Stephen A., Ratziu, Prof. Vlad, Sanyal, Arun J., Walczak, Robert

Volltext

SAT-299-Assessment of NIS4 clinical utility for identification of patients with active NASH (NAS ≥ 4) and significant fibrosis (F ≥ 2) in patients at risk of NASH von Hanf, Remy, Chaumat, Pierre, Majd, Zouher, Cordonnier, Genevieve, Brozek, John, Praca, Emilie, Sudrik, Fouad Ben, Bedossa, Prof. Pierre, Anstee, Prof. Quentin M., Francque, Prof. Sven, Harrison, Prof. Stephen A., Ratziu, Prof. Vlad, Mégnien, Sophie, Roudot, Alice, Hosmane, Suneil, Hum, Dean W., Sanyal, Arun J.

Volltext

Would You Figure It Out? Differential Diagnoses: Beyond the Usual von Albu, Evelyn, Lasseter, Heather

Volltext

Reply von Ratziu, Vlad

Volltext

Diagnostic accuracy of non-invasive tests for advanced fibrosis in patients with NAFLD: an individual patient data meta-analysis von Lee, Jenny A, Selvaraj, Emmanuel Anandraj, Staufer, Katharina, Younes, Ramy, Okanoue, Takeshi, Mahadeva, Sanjiv, Chan, Wah-Kheong, Eddowes, Peter J, Hirschfield, Gideon M, Newsome, Philip Noel, Wong, Vincent Wai-Sun, Fan, Jiangao, Cobbold, Jeremy F, Labenz, Christian, Lee, Myoung Seok, Wiegand, Johannes, Karlas, Thomas, Yılmaz, Yusuf, Aggarwal, Sandeep, Nakajima, Atsushi, Yoneda, Masato, Barget, Nathalie, Brosnan, M. Julia, Anstee, Quentin Mark, Neubauer, Stefan, Pavlides, Michael, Anstee, Quentin, Daly, Ann, Johnson, Katherine, Cockell, Simon, Bedossa, Pierre, Cordell, Heather, Day, Chris, Wonders, Kristy, Bossuyt, Patrick, Zafarmand, Hadi, Vali, Yasaman, Lee, Jenny, Clement, Karine, Schattenberg, Jörn, Vidal-Puig, Toni, Rodrigues-Cuenca, Sergio, Allison, Mike, Kamzolas, Ioannis, Petsalaki, Evangelia, Oresic, Matej, Mato, Jose M, Millet, Oscar, Berzigotti, Annalisa, Harrison, Stephen, Neubauer, Stefan, Cobbold, Jeremy, Mozes, Ferenc, Shumbayawonda, Elizabeth, Erpicum, Charlotte, Graham, Micheala, Romero-Gómez, Manuel, Gallego-Durán, Rocío, Fernández, Isabel, Montero-Vallejo, Rocío, Karsdal, Morten, Erhardtsen, Elisabeth, Rasmussen, Daniel, Leeming, Diana Julie, Fisker, Mette Juul, Tonini, Manuela, Bugianesi, Elisabetta, Rosso, Chiara, Armandi, Angelo, Marra, Fabio, Svegliati, Gianluca, Francque, Sven, Yki-Jarvinen, Hannele, Porthan, Kimmo, Mil, Saskia van, Valenti, Luca, Aithal, Guru, Newsome, Philip, Wenn, David, Rodrigues, Cecília Maria, Chaumat, Pierre, Hanf, Rémy, Duffin, Kevin, Tuthill, Theresa, McLeod, Euan, Ertle, Judith, Ostroff, Rachel, Alexander, Leigh, Kjær, Mette Skalshøi, Mikkelsen, Lars Friis, Brass, Clifford, Martic, Miljen, Loeffler, Juergen, Hanauer, Guido, Fournier, Céline, Pepin, Kay, Ehman, Richard, Myers, Joel, Myers, Rob, Doward, Lynda

Volltext

Biochemical markers of liver fibrosis in patients with hepatitis C virus infection: a prospective study von Imbert-Bismut, Françoise, Ratziu, Vlad, Pieroni, Laurence, Charlotte, Frederic, Benhamou, Yves, Poynard, Thierry

Volltext

Clinical Interest of Serum Alpha-2 Macroglobulin, Apolipoprotein A1, and Haptoglobin in Patients with Non-Alcoholic Fatty Liver Disease, with and without Type 2 Diabetes, before or... von Deckmyn, Olivier, Poynard, Thierry, Bedossa, Pierre, Paradis, Valérie, Peta, Valentina, Pais, Raluca, Ratziu, Vlad, Thabut, Dominique, Brzustowski, Angelique, Gautier, Jean-François, Cacoub, Patrice, Valla, Dominique

Volltext

Current considerations for clinical management and care of non-alcoholic fatty liver disease: Insights from the 1st International Workshop of the Canadian NASH Network (CanNASH) von Sebastiani, Giada, Patel, Keyur, Ratziu, Vlad, Feld, Jordan J, Neuschwander-Tetri, Brent A, Pinzani, Massimo, Petta, Salvatore, Berzigotti, Annalisa, Metrakos, Peter, Shoukry, Naglaa, Brunt, Elizabeth M, Tang, An, Cobbold, Jeremy F, Ekoe, Jean-Marie, Seto, Karen, Ghali, Peter, Chevalier, Stephanie, Anstee, Quentin M, Watson, Heather, Bajaj, Harpreet, Stone, James, Swain, Mark G, Ramji, Alnoor

Volltext

Clinicians' Perspectives on Barriers and Facilitators for the Adoption of Non-Invasive Liver Tests for NAFLD: A Mixed-Method Study von Vali, Yasaman, Eijk, Roel, Hicks, Timothy, Jones, William S, Suklan, Jana, Holleboom, Adriaan G, Ratziu, Vlad, Langendam, Miranda W, Anstee, Quentin M, Bossuyt, Patrick M M

Volltext

Biochemical markers of fibrosis in patients with chronic hepatitis C: A comparison with prothrombin time, platelet count, and age-platelet index von MYERS, Robert P, DE TORRES, Mercedes, IMBERT-BISMUT, Francoise, RATZIU, Vlad, CHARLOTTE, Frédéric, POYNARD, Thierry

Volltext

The Role of Noninvasive 13C-Octanoate Breath Test in Assessing the Diagnosis of Nonalcoholic Steatohepatitis von Fierbinteanu-Braticevici, Carmen, Calin-Necula, Ana-Maria, Enciu, Vlad-Teodor, Goran, Loredana, Pantea Stoian, Anca, Ancuta, Ioan, Viasu, Octav, Moldoveanu, Alexandru Constantin

Volltext

The Role of Noninvasive [sup.13]C-Octanoate Breath Test in Assessing the Diagnosis of Nonalcoholic Steatohepatitis von Fierbinteanu-Braticevici, Carmen, Calin-Necula, Ana-Maria, Enciu, Vlad-Teodor, Goran, Loredana, Pantea Stoian, Anca, Ancuta, Ioan, Viasu, Octav, Moldoveanu, Alexandru Constantin

Volltext

IL‐1 Receptor Antagonist in Combination with Pentoxifylline and Zinc for Severe Alcoholic Hepatitis: A Multicenter Randomized Double‐Bind Placebo‐Controlled Clinical Trial

Volltext

Clinical Cases in Hepatitis: Towards improving liver disease management in Australia von Strasser, Simone I, Thompson, Alexander J, Roberts, Stuart K, George, Jacob

Volltext

Author index

Volltext